(11)C-PIB PET in subjective cognitive impairment.

Area of Science:

• Neuroscience
• Gerontology
• Radiology

Background:

• Subjective Cognitive Impairment (SCI) is a potential early indicator of neurodegenerative diseases.
• Individuals with SCI may have an elevated risk for developing dementia.
• Understanding the underlying neuropathology of SCI is crucial for early diagnosis and intervention.

Purpose of the Study:

• To investigate amyloid-beta (Aβ) plaque burden in individuals with SCI.
• To compare amyloid load between SCI subjects and healthy controls using Positron Emission Tomography (PET) imaging.

Main Methods:

• Utilized 11C-PiB (Pittsburgh Compound B) PET scanning to quantify amyloid deposition.
• Included a cohort of 5 subjects diagnosed with SCI and 14 cognitively normal control participants.
• Analyzed PiB retention in specific cortical regions associated with Alzheimer's disease pathology.

Main Results:

• One out of five SCI subjects exhibited significantly elevated PiB retention in key cortical areas.
• The majority of SCI subjects and all control participants showed minimal PiB uptake.
• This finding suggests focal amyloid accumulation can occur in some individuals with SCI.

Conclusions:

• Amyloid pathology, detectable by PiB PET, may be present in a subset of individuals with SCI.
• These preliminary findings warrant larger, longitudinal investigations to confirm the association between SCI and amyloidosis.
• Further research is needed to elucidate the clinical significance and progression of amyloid accumulation in SCI.